Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 1
1992 1
1993 3
1994 3
1996 1
1997 1
1999 1
2003 1
2004 7
2006 2
2007 5
2008 1
2009 1
2010 4
2011 4
2012 10
2013 15
2014 14
2015 11
2016 7
2017 9
2018 10
2019 21
2020 21
2021 31
2022 43
2023 48
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
PCSK9 Inhibition: From Current Advances to Evolving Future.
Liu C, Chen J, Chen H, Zhang T, He D, Luo Q, Chi J, Hong Z, Liao Y, Zhang S, Wu Q, Cen H, Chen G, Li J, Wang L. Liu C, et al. Among authors: cen h. Cells. 2022 Sep 23;11(19):2972. doi: 10.3390/cells11192972. Cells. 2022. PMID: 36230934 Free PMC article. Review.
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation.
Zhang AMY, Xia YH, Lin JSH, Chu KH, Wang WCK, Ruiter TJJ, Yang JCC, Chen N, Chhuor J, Patil S, Cen HH, Rideout EJ, Richard VR, Schaeffer DF, Zahedi RP, Borchers CH, Johnson JD, Kopp JL. Zhang AMY, et al. Among authors: cen hh. Cell Metab. 2023 Dec 5;35(12):2119-2135.e5. doi: 10.1016/j.cmet.2023.10.003. Epub 2023 Oct 31. Cell Metab. 2023. PMID: 37913768
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial.
Wang T, Sun X, Qiu L, Su H, Cao J, Li Z, Song Y, Zhang L, Li D, Wu H, Zhang W, Li J, Zhou K, Zhou H, Yang Y, Li Z, Cen H, Cai Z, Zhang Z, Fu W, Jin J, Li F, Wu W, Gu X, Zhu W, Liu L, Li Z, Yi S, Bao H, Xu Z, Qiu L. Wang T, et al. Among authors: cen h. Clin Cancer Res. 2023 Apr 14;29(8):1440-1449. doi: 10.1158/1078-0432.CCR-22-2939. Clin Cancer Res. 2023. PMID: 36735519 Free PMC article. Clinical Trial.
PER2 integrates circadian disruption and pituitary tumorigenesis.
Guo L, Cen H, Weng J, He Y, Guo X, He D, Liu K, Duan S, Yang J, Zhang X, Qin Z, Wan Y, Chen Z, Wu B. Guo L, et al. Among authors: cen h. Theranostics. 2023 Apr 29;13(8):2657-2672. doi: 10.7150/thno.82995. eCollection 2023. Theranostics. 2023. PMID: 37215573 Free PMC article.
Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions.
Liu C, Chen H, Guo S, Liu Q, Chen Z, Huang H, Zhao Q, Li L, Cen H, Jiang Z, Luo Q, Chen X, Zhao J, Chen W, Yang PC, Wang L. Liu C, et al. Among authors: cen h. Biomed Pharmacother. 2023 Oct;166:115373. doi: 10.1016/j.biopha.2023.115373. Epub 2023 Aug 28. Biomed Pharmacother. 2023. PMID: 37647693 Free article. Review.
Advances in optical phenotyping of cereal crops.
Sun D, Robbins K, Morales N, Shu Q, Cen H. Sun D, et al. Among authors: cen h. Trends Plant Sci. 2022 Feb;27(2):191-208. doi: 10.1016/j.tplants.2021.07.015. Epub 2021 Aug 17. Trends Plant Sci. 2022. PMID: 34417079 Review.
253 results